Dynamics of soluble syndecan-1 in maternal serum during and after pregnancies complicated by preeclampsia: a nested case control study
- 24 August 2019
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 58 (1) , 50-58
Abstract
Background: We investigated the dynamics and the predictive value of soluble syndecan-1 (Sdc-1), a biomarker of endothelial dysfunction, in uneventful pregnancies and pregnancies complicated by preeclampsia (PE). Methods: Serum levels of Sdc-1 were measured at sequential time points during and after uneventful pregnancies (control, n = 95) and pregnancies developing PE (PE_long, n = 12). Levels were further measured in women with symptomatic PE (PE_state, n = 46) at a single time point. Results: Sdc-1 levels increased consistently throughout pregnancy. In the PE_long group Sdc-1 levels were lower at all visits throughout pregnancy, and reached significance in weeks 18–22 (p = 0.019), 23–27 (p = 0.009), 28–32 (p = 0.006) and 33–36 (p = 0.008). After delivery, Sdc-1 levels dropped sharply in all pregnancies but were significantly elevated in the PE_long group. The predictive power of Sdc-1 was evaluated analyzing receiver operating characteristic (ROC) curves. A significant power was reached at weeks 14–17 (area under the curve [AUC] 0.65, p = 0.025), 23–27 (AUC 0.73, p = 0.004) and 33–36 (AUC 0.75, p = 0.013). Conclusions: In summary, Sdc-1 levels were lower in women developing PE compared to uneventful pregnancies and Sdc-1 might be useful to predict PE. After delivery, Sdc-1 levels remained higher in women with PE. Additional studies investigating the link between glycocalyx degradation, Sdc-1 levels and placental and endothelial dysfunction in pregnancies affected by PE are warranted.Keywords
This publication has 38 references indexed in Scilit:
- Changes of placental syndecan-1 expression in preeclampsia and HELLP syndromeVirchows Archiv, 2013
- Molecular functions of syndecan-1 in diseaseMatrix Biology, 2012
- Angiogenic Factors and PreeclampsiaSeminars in Nephrology, 2011
- Vascular Dysfunction in Women With a History of Preeclampsia and Intrauterine Growth RestrictionCirculation, 2010
- Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitusDiabetologia, 2010
- The Global Impact of Pre-eclampsia and EclampsiaSeminars in Perinatology, 2009
- The Two Stage Model of Preeclampsia: Variations on the ThemePlacenta, 2009
- Shedding of the Endothelial Glycocalyx in Patients Undergoing Major Vascular Surgery With Global and Regional IschemiaCirculation, 2007
- Fetal Cells and Cell Free Fetal Nucleic Acids in Maternal Blood: New Tools to Study Abnormal Placentation?Placenta, 2005
- Inflammation- and ischemia-induced shedding of venular glycocalyxAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004